Kardigan, Inc.
Clinical trials sponsored by Kardigan, Inc., explained in plain language.
-
New pill aims to strengthen hearts in genetic cardiomyopathy
Disease control Recruiting nowThis study tests an experimental daily pill, danicamtiv, in 332 people with genetic or familial dilated cardiomyopathy (a weakened, enlarged heart). Participants take the drug or a placebo for about 6 months to see if it improves heart function and exercise ability. The goal is t…
Phase: PHASE2, PHASE3 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a simple pill delay heart valve surgery?
Disease control Recruiting nowThis study tests whether a daily medication called ataciguat can slow the progression of moderate aortic valve stenosis, a condition where the heart's aortic valve becomes narrowed. About 1,276 adults aged 50 and older will receive either ataciguat or a placebo for up to 3 years.…
Phase: PHASE2, PHASE3 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New shot aims to keep blood pressure in check after hospital discharge
Disease control Recruiting nowThis study tests a drug called tonlamarsen in adults who were recently hospitalized for dangerously high blood pressure. Participants receive either the drug or a placebo as a shot under the skin every 4 weeks. The goal is to see if tonlamarsen can lower blood pressure and reduce…
Phase: PHASE2 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC